Because the risk of gastroparesis is common to the entire class of drugs, any published literature regarding the association between gastroparesis and any GLP-1RA (such as tirzepatide, exenatide, liraglutide, albiglutide, dulaglutide, lixisenatide, and semaglutide) should have put Defendant on notice of the need to warn patients and prescribing physicians of the risk of gastroparesis associated with these drugs Defendant knew or should have known of this risk of gastroparesis from the clinical trials, medical literature, and case reports. Cynthia L
Reconstitution technique matters: injecting bacteriostatic water directly onto lyophilised powder creates shear forces that fragment peptide chains and reduce bioactivity
Intravesical treatments of bladder pain syndrome/interstitial cystitis
During the dose escalation phase, lower concentrations make it easier to measure small incremental increasesa critical safety feature when starting therapy
based medical team will review everything and follow up with questions
One nutrient that often comes into question is vitamin B12, especially for those considering B12 shots while breastfeeding
:format(webp))
